Skip to content

Clinical trials

Diabetes Mellitus trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Country / region: Singapore Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20051
20062
20072
20083
20094
20112
20121
20133
20148
20152
20163
20177
20186
201912
20206
20215
20229
20232
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Unknown status21
Recruiting7
Terminated6
Active, not recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Singapore Institute of Food and Biotechnology Innovation14
National University of Singapore8
Singapore General Hospital8
Novo Nordisk A/S7
Tan Tock Seng Hospital5
National University Health System, Singapore4
Allergan3
AstraZeneca3
Duke-NUS Graduate Medical School3
Eli Lilly and Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus89
Diabetes Mellitus, Type 228
Obesity10
Glucose Intolerance8
Hypertension5
Diabetes Complications4
Insulin Resistance4
Cardiovascular Diseases3
Coronary Artery Disease3
Gastroparesis3

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.